Leo Borchardt

Davis Polk is advising Mereo BioPharma Group plc on its combination with OncoMed Pharmaceuticals, Inc. The transaction, which is subject to customary closing conditions and the approval of…

Davis Polk advised the underwriters on an SEC-registered offering on Schedule B by Oesterreichische Kontrollbank Aktiengesellschaft of its $1 billion 3.125% guaranteed global notes due…

Davis Polk advised Roche Holdings, Inc. in connection with its Rule 144A/Regulation S offering of $750 million aggregate principal amount of 3.250% notes due 2023 and $650 million aggregate…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Equinor ASA (f/k/a Statoil ASA) of $1 billion aggregate principal amount of 3.625%…

Davis Polk advised the underwriters on an SEC-registered offering on Schedule B by Oesterreichische Kontrollbank Aktiengesellschaft (“OeKB”) of its $1.5 billion 2.875% guaranteed global…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Diageo Capital plc of $500 million aggregate principal amount of floating-rate notes due 2020, $500…

Davis Polk advised the joint global coordinators in connection with the initial public offering of CEVA Logistics AG on the SIX Swiss Exchange and concurrent private placement of…

Davis Polk advised the underwriters on an SEC-registered offering on Schedule B by Oesterreichische Kontrollbank Aktiengesellschaft (OeKB) of $1.5 billion 2.875% guaranteed global notes due…

Davis Polk advised Boozt AB (publ) on its initial public offering of shares and listing on NASDAQ Stockholm. The offering comprised 29,902,742 shares of common stock, of which 6,451…

Davis Polk is advising the joint bookrunners on a rights offering by Deutsche Bank AG of approximately 687,500,000 new ordinary shares of Deutsche Bank AG, which is expected to raise…